Relationship between Osteopontin and Bone Mineral Density | Zendy

A Vancea | Zendy; Oana Șerban | Zendy; Daniela Fodor | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Relationship between Osteopontin and Bone Mineral Density

Author(s) -

A Vancea,

Oana Șerban,

Daniela Fodor

Publication year - 2021

Publication title -

acta endocrinologica (bucharest)

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.249

H-Index - 13

eISSN - 1843-066X

pISSN - 1841-0987

DOI - 10.4183/aeb.2021.509

Subject(s) - osteopontin , bone mineral , osteoporosis , medicine , biomarker , clinical trial , bone density , bioinformatics , biology , biochemistry

Recent studies suggest that osteopontin (OPN) could be used as an early marker for the diagnosis of bone disorders. Considering the contradictory opinions in the literature, the objective of this systematic review is to analyse the current information regarding the relationship between OPN and bone mineral density (BMD), which represents an important process in the development of osteoporosis. We performed a literature search of clinical trials using the PubMed database, published between 1999-2020, and identified 7 studies that were eligible for analysis. The eligibility criteria were based on studies that analysed the relationship between osteopontin and bone mineral density on human subjects. Conclusion: serum OPN levels might be used as a biomarker of the early diagnosis of osteoporosis in postmenopausal women, with or without osteoporotic vertebral fractures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research